DOSSIER · 13F Holders · Q1 2026
NERVGEN PHARMA CORP
2 institutions still hold NERVGEN PHARMA CORP as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 64082X903·2 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
2 institutions reported NERVGEN PHARMA CORP in Q1 2026. GROUP ONE TRADING LLC leads at 88.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.